If you have been prescribed Mounjaro on the NHS for type 2 diabetes, or to treat obesity, then a planned price increase of the drug should not directly affect you
However, this isnt available with Medicare, Medicaid, or other government insurance plans
Semaglutide activates GLP-1 receptors throughout the body, triggering weight loss and metabolic changes that occasionally produce muscle cramping in the legs, shoulders, or abdomen
Semaglutide has been shown to improve insulin sensitivity in patients by enhancing the bodys response to insulin, which can be particularly beneficial for those with Hashimotos Thyroiditis, who often experience metabolic challenges, including insulin resistance, especially if they are overweight or have obesity